UBS Group’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $708K | Sell |
22,552
-153,580
| -87% | -$4.82M | ﹤0.01% | 4600 |
|
|
2025
Q1 | $5.23M | Buy |
176,132
+35,426
| +25% | +$1.05M | ﹤0.01% | 2931 |
|
|
2024
Q4 | $4.15M | Buy |
140,706
+96,987
| +222% | +$2.86M | ﹤0.01% | 3143 |
|
|
2024
Q3 | $1.36M | Buy |
43,719
+30,520
| +231% | +$950K | ﹤0.01% | 3333 |
|
|
2024
Q2 | $447K | Sell |
13,199
-81
| -0.6% | -$2.75K | ﹤0.01% | 3996 |
|
|
2024
Q1 | $863K | Buy |
13,280
+11,971
| +915% | +$778K | ﹤0.01% | 3655 |
|
|
2023
Q4 | $89.4K | Sell |
1,309
-169
| -11% | -$11.5K | ﹤0.01% | 5040 |
|
|
2023
Q3 | $76.7K | Sell |
1,478
-398
| -21% | -$20.7K | ﹤0.01% | 4895 |
|
|
2023
Q2 | $112K | Buy |
1,876
+221
| +13% | +$13.3K | ﹤0.01% | 4865 |
|
|
2023
Q1 | $81.8K | Sell |
1,655
-4,894
| -75% | -$242K | ﹤0.01% | 5011 |
|
|
2022
Q4 | $374K | Buy |
6,549
+627
| +11% | +$35.8K | ﹤0.01% | 3916 |
|
|
2022
Q3 | $278K | Sell |
5,922
-1,174
| -17% | -$55.1K | ﹤0.01% | 3825 |
|
|
2022
Q2 | $265K | Sell |
7,096
-1,312
| -16% | -$49K | ﹤0.01% | 3750 |
|
|
2022
Q1 | $251K | Sell |
8,408
-1,037
| -11% | -$31K | ﹤0.01% | 4216 |
|
|
2021
Q4 | $323K | Sell |
9,445
-4,556
| -33% | -$156K | ﹤0.01% | 4295 |
|
|
2021
Q3 | $519K | Buy |
14,001
+1,987
| +17% | +$73.7K | ﹤0.01% | 3709 |
|
|
2021
Q2 | $469K | Buy |
12,014
+341
| +3% | +$13.3K | ﹤0.01% | 3790 |
|
|
2021
Q1 | $497K | Buy |
+11,673
| New | +$497K | ﹤0.01% | 3931 |
|